Top
OR2L2 has not been detected as a mutational cancer driver

OR2L2
Ensembl id ENSG00000203663
Mutated samples
Coding Sequence 92 (1.4%)
Protein Affecting 66 (1.0%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all OR2L2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 31 20 5.42
Lung adenocarcinoma No 14 11 2.81
Breast carcinoma No 8 7 0.61
Lung squamous cell carcinoma No 9 5 2.87
Head and neck squamous cell carcinoma No 5 5 1.33
Esophageal carcinoma No 5 4 2.74
Small cell lung carcinoma No 3 3 4.35
Renal clear cell carcinoma No 2 2 0.48
Stomach adenocarcinoma No 4 2 1.24
Glioblastoma multiforme No 3 2 0.53
Bladder carcinoma No 1 1 1.02
Pancreas adenocarcinoma No 1 1 0.47
Lower grade glioma No 1 1 0.59
Serous ovarian adenocarcinoma No 1 1 0.32
Colorectal adenocarcinoma No 1 1 0.44
Prostate adenocarcinoma No 1 0 0.00
Uterine corpus endometrioid carcinoma No 2 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence